Margaret Dalesandro - 01 Sep 2023 Form 3 Insider Report for Ambrx Biopharma Inc.

Role
Director
Signature
/s/ Sonja Nelson, Attorney-in-Fact for Margaret Dalesandro
Issuer symbol
N/A
Transactions as of
01 Sep 2023
Net transactions value
$0
Form type
3
Filing time
06 Sep 2023, 17:49:15 UTC
Previous filing
29 Aug 2023
Next filing
06 Nov 2023

No securities are beneficially owned.

Remarks:

See Exhibit 24.1 for power of attorney. No securities are beneficially owned.